---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-072731"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:12:22.635212+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook

## Summary
- Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).
- Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).
- Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.
- Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.
- Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing.

## SEC filing metadata
- accession: 0001104659-25-072731
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/0001104659-25-072731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/tm2522098d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-072731
- JSON: https://secwatch.observer/filing/0001104659-25-072731.json
- Plain text: https://secwatch.observer/filing/0001104659-25-072731.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
